Approval · Notice of Compliance 9037 · 2007
BIOCLAV: Notice of Compliance 9037
Issued September 20, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9037
- Date
- September 20, 2007
- Company
- Novopharm LimitedMarkham, Ontario, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
- Canadian reference product
- CLAVAMOX TABLETS 250 MG (Pfizer Canada Inc., Animal Health Group)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BIOCLAV | 02299402 | Cancelled Post Market |
Medicinal ingredients
- AMOXICILLIN TRIHYDRATE 200 MG per TAB
- CLAVULANATE POTASSIUM 50 MG per TAB